Volume 152, Issue 6, Pages 1372-1382.e2 (May 2017) Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis Ira M. Jacobson, Eric Lawitz, Paul Y. Kwo, Christophe Hézode, Cheng-Yuan Peng, Anita Y.M. Howe, Peggy Hwang, Janice Wahl, Michael Robertson, Eliav Barr, Barbara A. Haber Gastroenterology Volume 152, Issue 6, Pages 1372-1382.e2 (May 2017) DOI: 10.1053/j.gastro.2017.01.050 Copyright © 2017 AGA Institute Terms and Conditions
Figure 1 SVR12 (full analysis set). aIncludes all patients who received at least 1 dose of study medication). DC, discontinuation; LTFU, lost-to-follow up. Gastroenterology 2017 152, 1372-1382.e2DOI: (10.1053/j.gastro.2017.01.050) Copyright © 2017 AGA Institute Terms and Conditions